Health Policy

1984 - 2025

Current editor(s): Katrien Kesteloot, Mia Defever and Irina Cleemput

From Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 113, issue 3, 2013

What (or who) causes health inequalities: Theories, evidence and implications? pp. 221-227

Gerry McCartney, Chik Collins and Mhairi Mackenzie

Reducing social inequities in health in Norway: Concerted action at state and local levels? pp. 228-235

Marie J. Tallarek née Grimm, Marit K. Helgesen and Elisabeth Fosse

Are migrants health policies aimed at improving access to quality healthcare? An analysis of Spanish policies pp. 236-246

María Luisa Vázquez, Rebeca Terraza-Núñez, Silvia S-Hernández, Ingrid Vargas, Lola Bosch, Andrea González, Sandra Pequeño, Raquel Cantos, Juan Ignacio Martínez and Luís Andrés López

Assessing inequalities in preventive care use in Europe pp. 247-257

Vincenzo Carrieri and Ansgar Wuebker

Five types of OECD healthcare systems: Empirical results of a deductive classification pp. 258-269

Katharina Böhm, Achim Schmid, Ralf Götze, Claudia Landwehr and Heinz Rothgang

The political economy of the public–private mix in heath expenditure: An empirical review of thirteen OECD countries pp. 270-283

Haizhen Mou

The formal–informal patient payment mix in European countries. Governance, economics, culture or all of these? pp. 284-295

Marzena Tambor, Milena Pavlova, Stanisława Golinowska, Christoph Sowada and Wim Groot

Exploring payment schemes used to promote integrated chronic care in Europe pp. 296-304

Apostolos Tsiachristas, Carolien Dikkers, Melinde R.S. Boland and Maureen P.M.H. Rutten-van Mölken

Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems pp. 305-312

Nicola Allen, Franz Pichler, Tina Wang, Sundip Patel and Sam Salek

Personalised medicine as a challenge for public pricing and reimbursement authorities – A survey among 27 European countries on the example of trastuzumab pp. 313-322

C. Leopold, S. Vogler, C. Habl, A.K. Mantel-Teeuwisse and J. Espin

Volume 113, issue 1, 2013

Cuts drive health system reforms in Spain pp. 1-7

Pedro Gallo and Joan Gené-Badia

Financial crisis and austerity measures in Greece: Their impact on health promotion policies and public health care pp. 8-12

Amalia A. Ifanti, Andreas A. Argyriou, Foteini H. Kalofonou and Haralabos P. Kalofonos

Austerity and health in Europe pp. 13-19

GianLuca Quaglio, Theodoros Karapiperis, Lieve Van Woensel, Elleke Arnold and David McDaid

Registries of implantable medical devices in Europe pp. 20-37

Charlotte Niederländer, Philip Wahlster, Christine Kriza and Peter Kolominsky-Rabas

A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe pp. 38-44

Carlos Campillo-Artero

How changes to Irish healthcare financing are affecting universal health coverage pp. 45-49

Adam D.M. Briggs

Evidenced Formal Coverage Index and universal healthcare enactment: A prospective longitudinal study of economic, social, and political predictors of 194 countries pp. 50-60

Andrea B. Feigl and Eric L. Ding

To what extent does employer-paid health insurance reduce the use of public hospitals? pp. 61-68

Rikke Søgaard, Morten Saaby and Mickael Bech

Effect of private health insurance on health care utilization in a universal public insurance system: A case of South Korea pp. 69-76

Boyoung Jeon and Soonman Kwon

PFI redux? Assessing a new model for financing hospitals pp. 77-85

Mark Hellowell

British Columbia's pay-for-performance experiment: Part of the solution to reduce emergency department crowding? pp. 86-92

Amy H.Y. Cheng and Jason M. Sutherland

An analysis of the inpatient charge and length of stay for patients with joint diseases in Korea: Specialty versus small general hospitals pp. 93-99

Sun Jung Kim, Eun-Cheol Park, Sung In Jang, Minjee Lee and Tae Hyun Kim

Decentralization and centralization of healthcare resources: Investigating the associations of hospital competition and number of cardiologists per hospital with mortality and resource utilization in Japan pp. 100-109

Sungchul Park, Jason Lee, Hiroshi Ikai, Tetsuya Otsubo and Yuichi Imanaka

Cancer Patient Pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in Denmark pp. 110-117

Heidi Buvarp Dyrop, Akmal Safwat, Peter Vedsted, Katja Maretty-Nielsen, Bjarne Hauge Hansen, Peter Holmberg Jørgensen, Thomas Baad-Hansen, Cody Bünger and Johnny Keller

Developing a universal tool for the prioritization of patients waiting for elective surgery pp. 118-126

Maite Solans-Domènech, Paula Adam, Cristian Tebé and Mireia Espallargues

Tackling hospital waiting times: The impact of past and current policies in the Netherlands pp. 127-133

Frederik T. Schut and Marco Varkevisser

To what degree is the governance of Dutch hospitals orientated towards quality in care? Does this really affect performance? pp. 134-141

Daan Botje, Niek S. Klazinga and Cordula Wagner

Effects of regulated competition on key outcomes of care: Cataract surgeries in the Netherlands pp. 142-150

Richard Heijink, Ilaria Mosca and Gert Westert

The public disclosure of accreditation information in Australia: Stakeholder perceptions of opportunities and challenges pp. 151-159

David Greenfield, Reece Hinchcliff, Marjorie Pawsey, Johanna Westbrook and Jeffrey Braithwaite

A theoretical framework for holistic hospital management in the Japanese healthcare context pp. 160-169

Hu-Chen Liu

Strengthening weak primary care systems: Steps towards stronger primary care in selected Western and Eastern European countries pp. 170-179

Peter P. Groenewegen, Paul Dourgnon, Stefan Greß, Arnoldas Jurgutis and Sara Willems

A systematic review on the effectiveness of group versus single-handed practice pp. 180-187

Gianfranco Damiani, Giulia Silvestrini, Bruno Federico, Mimma Cosentino, Mariagrazia Marvulli, Federico Tirabassi and Walter Ricciardi

Group versus single handed primary care: A performance evaluation of the care delivered to chronic patients by Italian GPs pp. 188-198

Modesta Visca, Andrea Donatini, Rosa Gini, Bruno Federico, Gianfranco Damiani, Paolo Francesconi, Leonardo Grilli, Carla Rampichini, Gabriele Lapini, Carlo Zocchetti, Francesco Di Stanislao, Antonio Brambilla, Fulvio Moirano and Donata Bellentani

Sex-based differences in income and response to proposed financial incentives among general practitioners in France pp. 199-205

William B. Weeks, Alain Paraponaris and Bruno Ventelou

Resources allocation and health care needs in diabetes care in Danish GP clinics pp. 206-215

Troels Kristensen, Kim Rose Olsen, Camilla Sortsø, Charlotte Ejersted, Janus Laust Thomsen and Anders Halling

Pharmacovigilance knowledge in family paediatricians. A survey study in Italy pp. 216-220

Paolo Pellegrino, Carla Carnovale, Dario Cattaneo, Valentina Perrone, Stefania Antoniazzi, Marco Pozzi, Ettore Napoleone, Maria Rosaria Filograna, Emilio Clementi and Sonia Radice

Volume 112, issue 3, 2013

Budget-makers and health care systems pp. 163-171

Joseph White

How experts are chosen to inform public policy: Can the process be improved? pp. 172-178

Sylvia Rowe, Nick Alexander, Connie M. Weaver, Johanna T. Dwyer, Christa Drew, Rhona S. Applebaum, Stephanie Atkinson, Fergus M. Clydesdale, Eric Hentges, Nancy A. Higley and M. Elizabeth Westring

Beyond tokenistic participation: Using representational artefacts to enable meaningful public participation in health service design pp. 179-186

Cecily Morrison and Andy Dearden

Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis pp. 187-196

Katharina E. Fischer, Wolf H. Rogowski, Reiner Leidl and Björn Stollenwerk

Rational care or rationing care? The case of cervical screening across the United Kingdom pp. 197-201

Hannah Flynn and Philippa Lewis

Applying rapid ‘de-facto’ HTA in resource-limited settings: Experience from Romania pp. 202-208

Ruth Lopert, Francis Ruiz and Kalipso Chalkidou

Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries pp. 209-216

Christine Leopold, Aukje Katja Mantel-Teeuwisse, Sabine Vogler, Kees de Joncheere, Richard Ogilvie Laing and Hubert G.M. Leufkens

Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents pp. 217-226

Hye-Young Kwon, Ji-Min Hong, Brian Godman and Bong-Min Yang

How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand pp. 227-233

Deborah Gleeson, Ruth Lopert and Papaarangi Reid

Evidence based policy decisions through a Bayesian approach: The case of a statin appraisal in the Netherlands pp. 234-240

Willem Woertman, Bram Vermeulen, Hans Groenewoud and Gert Jan van der Wilt

Multi-tier drugs assessment in a decentralised health care system. The Italian case-study pp. 241-247

Claudio Jommi, Enrico Costa, Alessandra Michelon, Maria Pisacane and Giovanna Scroccaro

Canadian policy makers’ views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers pp. 248-254

Steven G. Morgan, Paige A. Thomson, Jamie R. Daw and Melissa K. Friesen

What do Canadians think about physician–pharmaceutical industry interactions? pp. 255-263

Anne Holbrook, Joel Lexchin, Eleanor Pullenayegum, Craig Campbell, Bernard Marlow, Sue Troyan, Charles Weijer, Jeff Blackmer, Kevin Brazil and Don Willison

Worlds apart? An exploration of prescribing and medicine-taking decisions by patients, GPs and local policy makers pp. 264-272

Josie Solomon, Peter Knapp, D.K. Raynor and Karl Atkin

The public health benefit of medicines: How it has been assessed in France? The principles and results of five years’ experience pp. 273-284

Patrick Maison, Laura Zanetti, Anne Solesse, Gilles Bouvenot and Jacques Massol

Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time pp. 285-296

Frank G. Sandmann, Margreet G. Franken, Adri Steenhoek and Marc A. Koopmanschap

Volume 112, issue 1, 2013

Resolving the challenges in the international comparison of health systems: The must do's and the trade-offs pp. 4-8

Ian Forde, David Morgan and Niek S. Klazinga

International comparisons of health system performance among OECD countries: Opportunities and data privacy protection challenges pp. 9-18

Jillian Oderkirk, Elettra Ronchi and Niek Klazinga

Efficiency, effectiveness, equity (E3). Evaluating hospital performance in three dimensions pp. 19-27

Peter Davis, Barry Milne, Karl Parker, Phil Hider, Roy Lay-Yee, Jackie Cumming and Patrick Graham

Health system goals: A discrete choice experiment to obtain societal valuations pp. 28-34

Margreet Franken and Xander Koolman

Trends in cost sharing among selected high income countries—2000–2010 pp. 35-44

Zare Hossein and Anderson Gerard

Measuring the affordability of medicines: Importance and challenges pp. 45-52

L.M. Niëns and Werner Brouwer

International comparisons of waiting times in health care – Limitations and prospects pp. 53-61

Nina Viberg, Birger C. Forsberg, Michael Borowitz and Roger Molin

Public satisfaction as a measure of health system performance: A study of nine countries in the former Soviet Union pp. 62-69

Katharine Footman, Bayard Roberts, Anne Mills, Erica Richardson and Martin McKee

International comparisons of the technical efficiency of the hospital sector: Panel data analysis of OECD countries using parametric and non-parametric approaches pp. 70-79

Yauheniya Varabyova and Jonas Schreyögg

International hospital productivity comparison: Experiences from the Nordic countries pp. 80-87

Emma Medin, Unto Häkkinen, Miika Linna, Kjartan S. Anthun, Sverre Kittelsen and Clas Rehnberg

An international comparison of efficiency of inpatient mental health care systems pp. 88-99

Valerie Moran and Rowena Jacobs

Health care performance comparison using a disease-based approach: The EuroHOPE project pp. 100-109

Unto Häkkinen, Tor Iversen, Mikko Peltola, Timo T. Seppälä, Antti Malmivaara, Éva Belicza, Giovanni Fattore, Dino Numerato, Richard Heijink, Emma Medin and Clas Rehnberg

Methodological challenges in international performance measurement using patient-level administrative data pp. 110-121

Raul Kiivet, Reijo Sund, Miika Linna, Barbara Silverman, Heti Pisarev and Nurit Friedman

The international performance of healthcare systems in population health: Capabilities of pooled cross-sectional time series methods pp. 122-132

Nadine Reibling

The Belgian Health System Performance Report 2012: Snapshot of results and recommendations to policy makers pp. 133-140

France Vrijens, Françoise Renard, Pascale Jonckheer, Koen Van den Heede, Anja Desomer, Carine Van de Voorde, Denise Walckiers, Cécile Dubois, Cécile Camberlin, Joan Vlayen, Herman Van Oyen, Christian Léonard and Pascal Meeus

Methods to stimulate national and sub-national benchmarking through international health system performance comparisons: A Canadian approach pp. 141-147

Jeremy Veillard, Alexandra Moses McKeag, Brenda Tipper, Olga Krylova and Ben Reason

The International Cancer Benchmarking Partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom pp. 148-155

John Butler, Catherine Foot, Martine Bomb, Sara Hiom, Michel Coleman, Heather Bryant, Peter Vedsted, Jane Hanson and Mike Richards

Assessing quality in cross-country comparisons of health systems and policies: Towards a set of generic quality criteria pp. 156-162

Mirella Cacace, Stefanie Ettelt, Nicholas Mays and Ellen Nolte